Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.
about
Statins for primary cardiovascular prevention in the elderlyPrognostic stratification of older persons based on simple administrative data: development and validation of the "Silver Code," to be used in emergency department triage.The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study.Use of health services and medicines amongst Australian war veterans: a comparison of young elderly, near centenarians and centenarians.Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds.Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.Mitophagy is required for acute cardioprotection by simvastatin.Lipid-lowering therapy in older personsBias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.Immunity, ageing and cancer.Immunosupportive therapies in aging.Factors that may impact on immunosenescence: an appraisal.Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease.Comparison of the low-density lipoprotein cholesterol target value and the preventive effect of statins in elderly patients and younger patients.
P2860
Q26783401-4D6B9609-24D4-45E5-8944-B31E64E90A31Q33427357-5C56791F-EB02-4B89-9D99-BA43E41FB080Q33514949-38EE2576-9668-44ED-9EFF-BB42C134E93CQ33738315-9039C2BC-D0DA-4DBA-9224-F2E0225F3298Q34207468-170BBBD7-5605-4DD0-B5FC-E5946E8AE687Q34224601-E87E420D-E44E-4262-AACC-B7934DA1FF19Q34399751-2C0D62C2-9712-4006-ADF4-8F7F966E6FFEQ35232239-B5C8643D-FD69-4E68-8263-3EA5FA1E370BQ35734332-6E1F940A-8C27-4512-B537-6F7BE9415E7FQ36056243-D9C0803D-0F6E-44A4-8E71-2AFF6681A84FQ36059776-FD490F43-AD60-4941-81BE-95E5FE2BE737Q36809514-1BAE6271-4AF7-4CAC-9462-DCC2F98E5070Q36930979-65DEBB82-52F4-435D-B3E1-A243E24D6F25Q37017265-42BB7FCB-08C0-4EC0-B32A-94EFE294519FQ39864010-3277DD81-0881-465F-952B-9921EB1BB822Q40565108-2F1BF608-2DBE-4325-940C-E0CF58E1BC50Q42875427-A3BC68E0-54F3-46EB-A798-1D62B52A4874
P2860
Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@ast
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@en
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@nl
type
label
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@ast
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@en
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@nl
prefLabel
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@ast
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@en
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@nl
P2093
P2860
P50
P1476
Hydroxymethylglutaryl-CoA redu ...... for an age-statin interaction.
@en
P2093
Deron Galusha
Edward P Havranek
JoAnne Micale Foody
Saif S Rathore
P2860
P304
P356
10.1111/J.1532-5415.2005.00635.X
P407
P577
2006-03-01T00:00:00Z